Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XeUS Technologies is a medical technology company focused on commercializing X-ray-induced Ultrasound (X-EUS) for deep-tissue imaging and therapy. Based on pioneering research from Caltech, the company's platform uses X-rays to generate ultrasound waves within the body, allowing for high-resolution imaging of deep-seated organs and tumors that are difficult to reach with conventional ultrasound. This technology is being developed for applications in oncology, specifically for real-time guidance during biopsies and radiation therapy, as well as for triggered drug delivery. By integrating the penetration of X-rays with the resolution of ultrasound, XeUS Technologies aims to transform the diagnosis and treatment of complex cancers. The company is currently in the pre-clinical stage, refining its hardware and software for clinical translation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XeUS Technologies.